Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Non Small Cell Lung Cancer

Thousands of patients missing out on targeted cancer drugs

Thousands of cancer patients are missing out on personalised treatments each year because they are not being tested to see if they might benefit from them

Immunotherapy drugs show continued promise

A new immunotherapy drug has shown continued promise fortreating various types of cancer in a series of trials presented at a US conference.

Body’s cancer defences hijacked to make pancreatic and lung cancers more aggressive

Cancer Research UK scientists have discovered that a vital self-destruct switch in cells is hijacked.

‘Liquid biopsies’ could help spot genetic faults in lung cancer

Blood samples could offer an alternative to tumour biopsies in lung cancer patients, according to European researchers.

New drug 'more effective' than chemo for certain patients with advanced lung cancer

A new drug – crizotinib (Xalkori) – may be more beneficial than chemotherapy for some lung cancer patients.

Scientists trigger self-destruct switch in lung cancer cells

Scientists have found a drug combination that can trigger the self-destruct process in lung cancer cells.

Almost 2,000 lung cancer patients missing out on surgery every year

Around 1,800 lung cancer patients may be missing out on life-saving surgery each year, according to new statistics from Cancer Research UK.

Researchers reveal lung cancer can stay hidden for over 20 years

Scientists have discovered that lung cancers can lie dormant for over 20 years before suddenly turning into an aggressive form of the disease

Aspirin could combat permanent hearing loss caused by cancer drug

Cancer Research UK has launched a new trial to see if high doses of aspirin might help avoid hearing loss in patients given the drug cisplatin.

Revolutionary clinical trial aims to advance lung cancer treatment thanks to Cancer Research UK and Pharma partnership

Cancer Research UK is partnering with pharmaceutical companies to create a pioneering clinical trial for patients with advanced lung cancer